11/24
09:00 am
brkr
Indaba Capital Announces Sale of AST Revolution to Bruker
Low
Report
Indaba Capital Announces Sale of AST Revolution to Bruker
11/21
05:30 am
brkr
Bruker (NASDAQ:BRKR) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.
Medium
Report
Bruker (NASDAQ:BRKR) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.
11/20
10:05 am
brkr
Bruker (NASDAQ:BRKR) was given a new $60.00 price target on by analysts at Redburn Partners.
Medium
Report
Bruker (NASDAQ:BRKR) was given a new $60.00 price target on by analysts at Redburn Partners.
11/20
08:07 am
brkr
Bruker (NASDAQ:BRKR) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $60.00 price target on the stock.
Low
Report
Bruker (NASDAQ:BRKR) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $60.00 price target on the stock.
11/20
07:50 am
brkr
Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum [Yahoo! Finance]
Low
Report
Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum [Yahoo! Finance]
11/5
10:49 am
brkr
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at Wells Fargo & Company from $50.00 to $48.00. They now have an "overweight" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at Wells Fargo & Company from $50.00 to $48.00. They now have an "overweight" rating on the stock.
11/4
04:01 pm
brkr
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
Low
Report
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
11/4
02:03 pm
brkr
Bruker (NASDAQ:BRKR) had its price target raised by analysts at TD Cowen from $40.00 to $42.00. They now have a "hold" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) had its price target raised by analysts at TD Cowen from $40.00 to $42.00. They now have a "hold" rating on the stock.
11/4
12:09 pm
brkr
Bruker (NASDAQ:BRKR) had its "hold" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Bruker (NASDAQ:BRKR) had its "hold" rating reaffirmed by analysts at Cowen Inc.
11/4
08:43 am
brkr
Bruker (NASDAQ:BRKR) was given a new $43.00 price target on by analysts at UBS Group AG. They now have a "neutral" rating on the stock.
Medium
Report
Bruker (NASDAQ:BRKR) was given a new $43.00 price target on by analysts at UBS Group AG. They now have a "neutral" rating on the stock.
11/4
07:21 am
brkr
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
11/3
07:00 am
brkr
Bruker Reports Third Quarter 2025 Financial Results
Low
Report
Bruker Reports Third Quarter 2025 Financial Results
10/22
04:05 pm
brkr
Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast
Low
Report
Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast
10/13
10:03 am
brkr
Bruker Corporation (BRKR) Secures $10M Order for Nuclear Magnetic Resonance Instrumentation [Yahoo! Finance]
Low
Report
Bruker Corporation (BRKR) Secures $10M Order for Nuclear Magnetic Resonance Instrumentation [Yahoo! Finance]
10/7
08:27 am
brkr
LC-MS/MS-Based Diagnostics Market Trends and Competitive Landscape Report (2024 – 2034) [Yahoo! Finance]
Medium
Report
LC-MS/MS-Based Diagnostics Market Trends and Competitive Landscape Report (2024 – 2034) [Yahoo! Finance]
10/3
09:40 am
brkr
Global Preclinical Imaging Market Set to Reach USD 5.101 Million by 2029 | MarketsandMarkets™ [Yahoo! Finance]
Medium
Report
Global Preclinical Imaging Market Set to Reach USD 5.101 Million by 2029 | MarketsandMarkets™ [Yahoo! Finance]
10/3
07:09 am
brkr
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University [Yahoo! Finance]
Medium
Report
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University [Yahoo! Finance]
10/3
07:00 am
brkr
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University
Medium
Report
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University
10/2
09:12 am
brkr
Bruker (NASDAQ:BRKR) was given a new $40.00 price target on by analysts at Barclays PLC.
Low
Report
Bruker (NASDAQ:BRKR) was given a new $40.00 price target on by analysts at Barclays PLC.
9/23
12:14 pm
brkr
A-Alpha Bio Appoints Troy Lionberger as New Chief Business Officer to Drive Next Phase of Growth [Yahoo! Finance]
Low
Report
A-Alpha Bio Appoints Troy Lionberger as New Chief Business Officer to Drive Next Phase of Growth [Yahoo! Finance]